DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 133 filers reported holding DIPLOMAT PHARMACY INC in Q2 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $88,624,000 | +73.8% | 22,156 | +112.9% | 0.00% | – |
Q3 2019 | $50,984,000 | -24.9% | 10,405 | -6.7% | 0.00% | – |
Q2 2019 | $67,904,000 | -10.8% | 11,150 | -14.9% | 0.00% | – |
Q1 2019 | $76,134,000 | +136.1% | 13,104 | +446.9% | 0.00% | – |
Q4 2018 | $32,250,000 | -48.8% | 2,396 | -26.1% | 0.00% | – |
Q3 2018 | $62,966,000 | -66.2% | 3,244 | -55.4% | 0.00% | – |
Q2 2018 | $186,102,000 | -69.9% | 7,281 | -76.3% | 0.00% | -100.0% |
Q1 2018 | $618,665,000 | +26.5% | 30,703 | +26.0% | 0.00% | 0.0% |
Q4 2017 | $489,126,000 | -5.1% | 24,371 | -2.0% | 0.00% | 0.0% |
Q3 2017 | $515,286,000 | +148.8% | 24,881 | +77.8% | 0.00% | 0.0% |
Q2 2017 | $207,082,000 | +46.3% | 13,992 | +57.6% | 0.00% | – |
Q1 2017 | $141,572,000 | +44.0% | 8,876 | +13.8% | 0.00% | – |
Q4 2016 | $98,318,000 | -48.4% | 7,803 | +14.8% | 0.00% | -100.0% |
Q3 2016 | $190,412,000 | -53.5% | 6,798 | -41.9% | 0.00% | -50.0% |
Q2 2016 | $409,570,000 | +192.0% | 11,702 | +128.6% | 0.00% | +100.0% |
Q1 2016 | $140,261,000 | -41.0% | 5,119 | -26.3% | 0.00% | 0.0% |
Q4 2015 | $237,692,000 | +10.7% | 6,946 | -7.0% | 0.00% | 0.0% |
Q3 2015 | $214,642,000 | +59.4% | 7,471 | +148.2% | 0.00% | – |
Q2 2015 | $134,698,000 | +961.4% | 3,010 | +720.2% | 0.00% | – |
Q1 2015 | $12,691,000 | – | 367 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|